| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 732800 | methyl 4-[3-chloro-4-(3-chloro-2-methylanilino)-2,5-dioxo-2,5-dihyd ro-1H-1-pyrrolylmethyl]benzoate | 0.0171439890681608 | 0.25214254 |
| NSC 744633 | Null | 0.0171439890681608 | 0.24504363 |
| NSC 747558 | 6-(4-Ethylphenyl)-2-benzenesulfonamidepyridazine-3(2H)-one | 0.0171439890681608 | 0.36875333 |
| NSC 748900 | [(20S)-20-(N,N-dimethylamino)-3a-(tigloylamino)-5a-preg-2a -O-acetate-4a-ol] | 0.0171439890681608 | 0.31415942 |
| NSC 754081 | 7-(4-methoxybenzyl)-4,4-dimethyl-6-phenyl-5,7-dihydro-4H-isoxazolo[5,4-e]isoindole | 0.0171439890681608 | 0.20365639 |
| NSC 757982 | Null | 0.0171439890681608 | 0.3699833 |
| NSC 12455 | Acid Alizarin Red B | 0.0181211508101519 | 0.36988577 |
| NSC 128571 | Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) | 0.0181211508101519 | 0.29265039 |
| NSC 169774 | Bromocriptine methanesulfonate | 0.0181211508101519 | 0.49021358 |
| NSC 26074 | Null | 0.0181211508101519 | 0.23494101 |